TickerFactsScreenerDevelopers

VYNE Therapeutics Inc. (VYNE) — Total Assets

Annual figures by fiscal year, from SEC filings.

2016: $42.05M2017: $66.87M2018: $139.93M2019: $81.16M2020: $93.74M2021: $67.05M2022: $40.76M2023: $97.69M2024: $66.91M2025: $30.16M$30.16M
2016Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$30.16M-54.9%
2024$66.91M-31.5%
2023$97.69M+139.7%
2022$40.76M-39.2%
2021$67.05M-28.5%
2020$93.74M+15.5%
2019$81.16M-42.0%
2018$139.93M+109.3%
2017$66.87M+59.0%
2016$42.05M—